Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cacodylic acid is an organoarsenic compound with the formula (CH3)2AsO2H. It is the simplest of the arsinic acids and appears as a colorless solid that is soluble in water. Cacodylic acid and its salts (notably sodium cacodylate) have been widely used as contact herbicides for defoliating or desiccating plants, including use during the Vietnam War as part of "Agent Blue." In addition to agricultural applications, sodium cacodylate serves as a buffering agent in biological sample preparation for electron microscopy and protein crystallography. The mechanism of action for its herbicidal effect involves disruption of plant metabolism due to arsenic toxicity[3][4][5]. Cacodylic acid has also been studied for mutagenicity and carcinogenicity; it can induce DNA damage in mammalian cells[5][6]. It is not primarily developed or marketed as a pharmaceutical drug. Developers: APC Holdings Corp
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cacodylic acid.